Clinical study on the relationship between B lymphocyte ratio and IgA antibody level in the second trimester of pregnancy and the prognosis of gestational diabetes mellitus

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036386

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

Normal glucose group versus impaired glucose tolerance group versus impaired fasting glucose group versus diabetes group:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women of childbearing age, aged between 25 and 35 years old, with no previous history of diabetes in our hospital will be include in this study.

Exclusion criteria

Exclusion criteria: The following categories of pregnant women will not be included in the study: 1. Pregnant women with age = 35 years old; 2. Women with previous history of diabetes; 3. OGTT examination during pregnancy indicates PGDM, that is: fasting plasma glucose >= 7.0mmol/l; or 75g oral glucose tolerance test 2 hours after taking glucose >= 11.1mmol/l; or accompanied by typical hyperglycemia symptoms or hyperglycemic crisis, and random blood glucose >= 11.1mmol/l; or glycosylated hemoglobin >= 6.5%. 4. Pregnant women with gestational hypertension, autoimmune diseases such as systemic lupus erythematosus, etc.

Design outcomes

Primary

Measure	Time frame
B lymphocyte ratio;IgA antibody level;	—

Countries

China

Contacts

Public ContactYan Zhuang

Shanghai General Hospital

yan.zhuang@shgh.cn+86 13761562832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026